Jan Novák

21.8k total citations · 3 hit papers
199 papers, 13.1k citations indexed

About

Jan Novák is a scholar working on Nephrology, Molecular Biology and Immunology. According to data from OpenAlex, Jan Novák has authored 199 papers receiving a total of 13.1k indexed citations (citations by other indexed papers that have themselves been cited), including 130 papers in Nephrology, 72 papers in Molecular Biology and 62 papers in Immunology. Recurrent topics in Jan Novák's work include Renal Diseases and Glomerulopathies (126 papers), Platelet Disorders and Treatments (49 papers) and Glycosylation and Glycoproteins Research (46 papers). Jan Novák is often cited by papers focused on Renal Diseases and Glomerulopathies (126 papers), Platelet Disorders and Treatments (49 papers) and Glycosylation and Glycoproteins Research (46 papers). Jan Novák collaborates with scholars based in United States, Japan and Czechia. Jan Novák's co-authors include Bruce A. Julian, Matthew B. Renfrow, Jiří Městecký, Colin Reily, Hitoshi Suzuki, Robert Wyatt, Tyler J. Stewart, Zina Moldoveanu, Milan Tomana and Ali G. Gharavi and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Jan Novák

193 papers receiving 12.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Glycosylation in health and disease

2019 1.4k citations Colin Reily, Matthew B. Renfrow et al. profile →
The Pathophysiology of IgA Nephropathy

2011 575 citations Hitoshi Suzuki, Krzysztof Kiryluk et al. Journal of the American Society of Nephrology profile →
IgA nephropathy

2016 360 citations Kar Neng Lai, Sydney Tang et al. Nature Reviews Disease Primers profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jan Novák United States	63	8.0k	4.3k	3.9k	2.9k	2.4k	199	13.1k
Hitoshi Suzuki Japan	43	4.5k 0.6×	1.3k 0.3×	2.0k 0.5×	1.6k 0.5×	1.5k 0.6×	271	7.2k
Renato C. Monteiro France	55	2.3k 0.3×	1.9k 0.4×	4.6k 1.2×	1.1k 0.4×	926 0.4×	173	8.9k
Thomas S. Edgington United States	65	633 0.1×	4.0k 0.9×	2.9k 0.7×	6.0k 2.1×	306 0.1×	204	14.4k
Falk Nimmerjahn Germany	61	353 0.0×	7.2k 1.7×	10.4k 2.7×	1.4k 0.5×	952 0.4×	205	18.2k
Mart Mannik United States	46	750 0.1×	1.9k 0.4×	2.7k 0.7×	802 0.3×	322 0.1×	140	6.2k
Harry Holthöfer Finland	47	2.4k 0.3×	3.7k 0.9×	879 0.2×	201 0.1×	450 0.2×	162	7.3k
Reinhard Voll Germany	54	477 0.1×	4.5k 1.0×	8.0k 2.0×	747 0.3×	556 0.2×	244	13.7k
Cynthia C. Nast United States	51	2.0k 0.3×	2.4k 0.5×	1.6k 0.4×	257 0.1×	398 0.2×	152	7.7k
Leticia Quintanilla-Martı́nez Germany	54	218 0.0×	2.8k 0.6×	1.8k 0.5×	1.1k 0.4×	4.0k 1.7×	307	10.2k
Nobuhiko Kayagaki Japan	57	1.0k 0.1×	11.5k 2.7×	9.2k 2.4×	1.1k 0.4×	386 0.2×	98	17.4k

Countries citing papers authored by Jan Novák

Since Specialization

Citations

This map shows the geographic impact of Jan Novák's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Novák with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Novák more than expected).

Fields of papers citing papers by Jan Novák

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Novák. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Novák. The network helps show where Jan Novák may publish in the future.

Co-authorship network of co-authors of Jan Novák

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Novák. A scholar is included among the top collaborators of Jan Novák based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Novák. Jan Novák is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cunningham, Madeleine W., Stacy Hall, Nicolas Maillard, et al.. (2025). Proteomic Analysis of Circulating IgA1-Containing Immune Complexes in Patients with IgA Nephropathy. Kidney International Reports. 10(10). 3611–3623.

Reily, Colin, Zina Moldoveanu, Tiziano Pramparo, et al.. (2024). Sparsentan ameliorates glomerular hypercellularity and inflammatory-gene networks induced by IgA1-IgG immune complexes in a mouse model of IgA nephropathy. American Journal of Physiology-Renal Physiology. 326(5). F862–F875. 12 indexed citations

Novák, Jan. (2024). Pathogenesis of IgA nephropathy: Omics data inform glycomedicine. Nephrology. 29(S2). 18–22.

Novák, Jan, et al.. (2023). Centre of pressure changes during stance but not during gait in young women after alcohol intoxication. PeerJ. 11. e16511–e16511. 1 indexed citations

King, R. Glenn, et al.. (2022). Cytokines and Production of Aberrantly O -Glycosylated IgA1, the Main Autoantigen in IgA Nephropathy. Journal of Interferon & Cytokine Research. 42(7). 301–315. 7 indexed citations

Hastings, Margaret, Dana V. Rizk, Krzysztof Kiryluk, et al.. (2021). IgA vasculitis with nephritis: update of pathogenesis with clinical implications. Pediatric Nephrology. 37(4). 719–733. 40 indexed citations

Yamaguchi, Hisateru, Kazuki Nakajima, Tomohiro Mizuno, et al.. (2020). Analysis of O-glycoforms of the IgA1 hinge region by sequential deglycosylation. Scientific Reports. 10(1). 671–671. 26 indexed citations

Maixnerová, Dita, Stacy Hall, Colin Reily, et al.. (2019). Galactose-deficient IgA1 and the corresponding IgG autoantibodies predict IgA nephropathy progression. PLoS ONE. 14(2). e0212254–e0212254. 45 indexed citations

Lai, Kar Neng, Sydney Tang, Francesco Paolo Schena, et al.. (2016). IgA nephropathy. Nature Reviews Disease Primers. 2(1). 16001–16001. 360 indexed citations breakdown →

10.

Suzuki, Yusuke, Keiichi Matsuzaki, Hitoshi Suzuki, et al.. (2014). Serum levels of galactose-deficient immunoglobulin (Ig) A1 and related immune complex are associated with disease activity of IgA nephropathy. Clinical and Experimental Nephrology. 18(5). 770–777. 68 indexed citations

11.

Berthoux, F., Hitoshi Suzuki, Lise Thibaudin, et al.. (2012). Autoantibodies Targeting Galactose-Deficient IgA1 Associate with Progression of IgA Nephropathy. Journal of the American Society of Nephrology. 23(9). 1579–1587. 206 indexed citations

12.

Novák, Jan, Bruce A. Julian, Jiří Městecký, & Matthew B. Renfrow. (2012). Glycosylation of IgA1 and pathogenesis of IgA nephropathy. Seminars in Immunopathology. 34(3). 365–382. 96 indexed citations

13.

Suzuki, Hitoshi, Krzysztof Kiryluk, Jan Novák, et al.. (2011). The Pathophysiology of IgA Nephropathy. Journal of the American Society of Nephrology. 22(10). 1795–1803. 575 indexed citations breakdown →

14.

Takahashi, Kazuo, et al.. (2011). Production of N-acetylgalactosaminyl-transferase 2 (GalNAc-T2) fused with secretory signal Igκ in insect cells. Protein Expression and Purification. 81(2). 175–180. 10 indexed citations

15.

Suzuki, Hitoshi, Run Fan, Zhixin Zhang, et al.. (2009). Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity. Journal of Clinical Investigation. 119(6). 1668–77. 341 indexed citations

16.

Městecký, Jiří, Milan Tomana, Zina Moldoveanu, et al.. (2008). Role of Aberrant Glycosylation of IgA1 Molecules in the Pathogenesis of IgA Nephropathy. Kidney & Blood Pressure Research. 31(1). 29–37. 67 indexed citations

17.

Janout, Vladimír, et al.. (2004). Lung Cancer Incidence in the Czech Republic: A Time-Trend Study. Oncology Research and Treatment. 27(4). 376–379. 3 indexed citations

18.

Chen, Ping, et al.. (2001). Effect of amino acid substitutions in conserved residues in the leader peptide on biosynthesis of the lantibiotic mutacin II. FEMS Microbiology Letters. 195(2). 139–144. 36 indexed citations

19.

Smith, Leif, et al.. (2000). Covalent structure of mutacin 1140 and a novel method for the rapid identification of lantibiotics. European Journal of Biochemistry. 267(23). 6810–6816. 1 indexed citations

20.

Novák, Jan, N Muñoz, F. Xavier Bosch, et al.. (1994). Presence Of Antibodies To Seven Human Papillomavirus Type 16-Derived. The Journal of Infectious Diseases. 170(6). 1424–1431. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact